TAMOXIFEN Novaldex Mammaton amoxifen CAS 10540-29-1 CAS 2363-59-9 CAS 54965-24-1
- Norq Marash
- 16/01/2025 12:11
Individual
-
Company name
TAMOXIFEN Novaldex Mammaton amoxifen CAS 10540-29-1 CAS 2363-59-9 CAS 54965-24-1
-
Workspace
Architecture, Construction
-
Schedule
Full time
-
Education
Secondary
-
Experience
CAS No.2363-59-9
CAS No.10540-29-1
Chemical Name:Tamoxifen
SynonymsTAMOXIFEN BASE;Novaldex;Mammaton;amoxifen;z-tamoxifen;Genox;C07108;Tamoxen;ici47699;TAMOXIFEN
CBNumber:CB9438781
Molecular Formula:C26H29NO
Molecular Weight:371.51
Melting point 97-98 °C(lit.)
Boiling point 501.18°C (rough estimate)
Density 1.0630 (rough estimate)
vapor pressure 0Pa at 25℃
refractive index 1.6000 (estimate)
storage temp. 2-8°C
Uses
1. Treatment for Women with metastatic breast cancer recurrence.
2. Used as adjuvant therapy after surgery for breast cancer metastasis, and relapse prevention.
3. For the treatment of ovarian cancer, endometrial cancer and endometriosis. -
Sex
-
Age
-
Description
-
CAS No.2363-59-9
CAS No.10540-29-1
Chemical Name:Tamoxifen
SynonymsTAMOXIFEN BASE;Novaldex;Mammaton;amoxifen;z-tamoxifen;Genox;C07108;Tamoxen;ici47699;TAMOXIFEN
CBNumber:CB9438781
Molecular Formula:C26H29NO
Molecular Weight:371.51
Melting point 97-98 °C(lit.)
Boiling point 501.18°C (rough estimate)
Density 1.0630 (rough estimate)
vapor pressure 0Pa at 25℃
refractive index 1.6000 (estimate)
storage temp. 2-8°C
Uses
1. Treatment for Women with metastatic breast cancer recurrence.
2. Used as adjuvant therapy after surgery for breast cancer metastasis, and relapse prevention.
3. For the treatment of ovarian cancer, endometrial cancer and endometriosis.
